Marker Assisted Selective ThErapy in Rare Cancers: Knowledge Database Establishing registrY Asia

RecruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

November 30, 2021

Primary Completion Date

March 31, 2027

Study Completion Date

March 31, 2030

Conditions
Rare Malignant Neoplasm
Interventions
OTHER

Genomic sequence

Genomic sequence

Trial Locations (18)

1102

RECRUITING

St. Luke's Medical Center, Manila

50586

RECRUITING

Hospital Kuala Lumpur, Kuala Lumpur

62250

RECRUITING

Institut Kanser negara, Putrajaya

93586

RECRUITING

Sarawak General Hospital, Kuching

100225

RECRUITING

National Taiwan University Hospital, Taipei

104-0045

RECRUITING

National Cancer Center Hospital, Japan, Chuo-ku

Unknown

RECRUITING

Hospital Sultan Ismail, Johor Bahru

RECRUITING

Hospital Pulau Pinang, Pulau Pinang

RECRUITING

University Malaya Medical Center, Kuala Lumpur

RECRUITING

National Cancer Center Korea, Seoul

RECRUITING

Taipei Veterans General Hospital, Taipei

RECRUITING

Mahidol University by Faculty of Medicine, Ramathibodi Hospita, Bangkok

RECRUITING

Mahidol University by Faculty of Medicine, Siriraj Hospital, Bangkok

NOT_YET_RECRUITING

Maharaj Nakorn Chiang Mai Hospital, Chiang Mai

RECRUITING

Faculty of Medicine, Prince of Songkla University, Hat Yai

RECRUITING

Khon Kaen University by Faculty of Medicine, Srinagarind Hospital, Khon Kaen

RECRUITING

National Cancer Vietnam, Hanoi

NOT_YET_RECRUITING

Ho Chi Minh City Oncology Hospital, Ho Chi Minh City

All Listed Sponsors
lead

National Cancer Center, Japan

OTHER_GOV